Anti-StARD13 antibody
-
概述
- 产品描述This gene encodes a protein which contains an N-terminal sterile alpha motif (SAM) for protein-protein interactions, followed by an ATP/GTP-binding motif, a GTPase-activating protein (GAP) domain, and a C-terminal STAR-related lipid transfer (START) domain. It may be involved in regulation of cytoskeletal reorganization, cell proliferation, and cell motility, and acts as a tumor suppressor in hepatoma cells. The gene is located in a region of chromosome 13 that is associated with loss of heterozygosity in hepatocellular carcinomas. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
- 产品名称Anti-StARD13 antibody
- 分子量125 kDa
- 种属反应性Human,Mouse
- 验证应用WB,IF
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human STA13. AA range:101-150
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称
- STARD13 antibody; DLC2 antibody; GT650 antibody; StAR-related lipid transfer protein 13 antibody; 46H23.2 antibody; Deleted in liver cancer 2 protein antibody; DLC-2 antibody; Rho GTPase-activating protein antibody; START domain-containing protein 13 antibody; StARD13 antibody;
-
应用
WB: 1:500-1:2000
IF: 1:100-1:500
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
